Paul Edick, CEO of Durata Therapeutics, Inc., bought 3,000 shares of Durata Therapeutics, Inc. (Stock Symbol: DRTX) at $45.70 per share for a total amount of $15.3 thousand on June 12, 2014. Continue reading CEO Paul R. Edick, Durata Therapeutics, Inc. Insider Buys $15,300 of Shares